| Literature DB >> 29734295 |
Zehua Bao1, Mohammad HamediRad2, Pu Xue2, Han Xiao1, Ipek Tasan3, Ran Chao2, Jing Liang4, Huimin Zhao1,2,3,4,5,6.
Abstract
We developed a CRISPR-Cas9- and homology-directed-repair-assisted genome-scale engineering method named CHAnGE that can rapidly output tens of thousands of specific genetic variants in yeast. More than 98% of target sequences were efficiently edited with an average frequency of 82%. We validate the single-nucleotide resolution genome-editing capability of this technology by creating a genome-wide gene disruption collection and apply our method to improve tolerance to growth inhibitors.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29734295 DOI: 10.1038/nbt.4132
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908